IS7500A - thurrdufts samsetningar - Google Patents

thurrdufts samsetningar

Info

Publication number
IS7500A
IS7500A IS7500A IS7500A IS7500A IS 7500 A IS7500 A IS 7500A IS 7500 A IS7500 A IS 7500A IS 7500 A IS7500 A IS 7500A IS 7500 A IS7500 A IS 7500A
Authority
IS
Iceland
Prior art keywords
dry powder
powder formulations
formulations
dry
powder
Prior art date
Application number
IS7500A
Other languages
English (en)
Inventor
Charles Roche Trevor
Arvind Bulsara Pallav
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of IS7500A publication Critical patent/IS7500A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
IS7500A 2002-04-13 2004-10-11 thurrdufts samsetningar IS7500A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0208608.0A GB0208608D0 (en) 2002-04-13 2002-04-13 Composition
PCT/GB2003/001542 WO2003088943A1 (en) 2002-04-13 2003-04-10 Dry powder compositions

Publications (1)

Publication Number Publication Date
IS7500A true IS7500A (is) 2004-10-11

Family

ID=9934855

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7500A IS7500A (is) 2002-04-13 2004-10-11 thurrdufts samsetningar

Country Status (19)

Country Link
US (1) US20050244340A1 (is)
EP (1) EP1494644A1 (is)
JP (1) JP2005530733A (is)
KR (1) KR20040099436A (is)
CN (1) CN1658839A (is)
AR (1) AR039409A1 (is)
AU (1) AU2003217073A1 (is)
BR (1) BR0309114A (is)
CA (1) CA2481467A1 (is)
GB (1) GB0208608D0 (is)
IL (1) IL164420A0 (is)
IS (1) IS7500A (is)
MX (1) MXPA04010080A (is)
NO (1) NO20044497L (is)
PL (1) PL373294A1 (is)
RU (1) RU2004130439A (is)
TW (1) TW200404008A (is)
WO (1) WO2003088943A1 (is)
ZA (1) ZA200408245B (is)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003024396A2 (en) 2001-09-17 2003-03-27 Glaxo Group Limited Dry powder medicament formulations
SE526509C2 (sv) * 2003-06-19 2005-09-27 Microdrug Ag Kombinerade doser av formoterol och budesonid separerade på en gemensam dosbädd
EP1643973A1 (en) * 2003-07-11 2006-04-12 Glaxo Group Limited Pharmaceutical formulations comprising magnesium stearate
EP1643974A1 (en) * 2003-07-11 2006-04-12 Glaxo Group Limited Inhalable pharmaceutical formulations comprising a sugar ester
AR049384A1 (es) 2004-05-24 2006-07-26 Glaxo Group Ltd Derivados de purina
WO2006066907A1 (en) * 2004-12-21 2006-06-29 Glaxo Group Limited Pharmaceutical formulations
ES2613391T3 (es) * 2005-02-10 2017-05-24 Glaxo Group Limited Procedimientos de fabricación de lactosa que utilizan técnicas de preclasificación y formulaciones farmacéuticas formadas a partir de la misma
GB0514809D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds
JP2009545579A (ja) 2006-08-01 2009-12-24 グラクソ グループ リミテッド ピラゾロ［３，４−ｂ］ピリジン化合物、及びｐｄｅ４阻害薬としてのその使用
GB0921075D0 (en) * 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
EP2991625A1 (en) * 2013-04-29 2016-03-09 Sanofi SA Inhalable pharmaceutical compositions and the inhaler devices containing them
US20170252333A1 (en) * 2014-08-01 2017-09-07 Luxena Pharmaceuticals, Inc. Palonosetron formulations and uses thereof
PT109030B (pt) * 2015-12-15 2019-09-25 Hovione Farmaciência, S.A. Preparação de partículas inaláveis de zafirlucaste
CN110237373B (zh) * 2018-03-08 2023-06-02 润生药业有限公司 一种生产用于联合用药的药物载体的装置及方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR8007911A (pt) * 1979-12-06 1981-06-16 Glaxo Group Ltd Inalador aperfeicoado
SE448277B (sv) * 1985-04-12 1987-02-09 Draco Ab Indikeringsanordning vid en doseringsanordning for lekemedel
FI88112C (fi) * 1985-07-30 1993-04-13 Glaxo Group Ltd Anordning foer administrering av laekemedel till patienter
GB9004781D0 (en) * 1990-03-02 1990-04-25 Glaxo Group Ltd Device
JPH04220268A (ja) * 1990-12-19 1992-08-11 Olympus Optical Co Ltd バルーンカテーテル
ZA9711732B (en) * 1996-12-31 1998-12-28 Quadrant Holdings Cambridge Methods and compositions for improvement bioavailability of bioactive agents for mucosal delivery
DK0994887T3 (da) * 1997-07-03 2003-03-17 Elan Drug Delivery Ltd Modificerede glycosider, præparater omfattet deraf og fremgangsmåder til anvendelse deraf
US6352722B1 (en) * 1997-12-23 2002-03-05 Quadrant Holdings Cambridge Limited Derivatized carbohydrates, compositions comprised thereof and methods of use thereof
EP1862164A3 (de) * 1998-11-13 2012-12-26 Jagotec AG Trockenpulver zur Inhalation
GB9916316D0 (en) * 1999-07-12 1999-09-15 Quadrant Holdings Cambridge Dry powder compositions
GB0015981D0 (en) * 2000-06-29 2000-08-23 Glaxo Group Ltd Novel process for preparing crystalline particles
GB0020616D0 (en) * 2000-08-21 2000-10-11 Quadrant Holdings Cambridge Particulates
EP1343521A2 (en) * 2000-12-01 2003-09-17 Battelle Memorial Institute Method for the stabilizing biomolecules (e.g. insulin) in liquid formulations
GB0103630D0 (en) * 2001-02-14 2001-03-28 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
RU2004130439A (ru) 2005-06-10
WO2003088943A1 (en) 2003-10-30
NO20044497L (no) 2004-11-15
JP2005530733A (ja) 2005-10-13
US20050244340A1 (en) 2005-11-03
TW200404008A (en) 2004-03-16
PL373294A1 (en) 2005-08-22
GB0208608D0 (en) 2002-05-22
BR0309114A (pt) 2005-02-01
AR039409A1 (es) 2005-02-16
KR20040099436A (ko) 2004-11-26
CA2481467A1 (en) 2003-10-30
ZA200408245B (en) 2007-03-28
IL164420A0 (en) 2005-12-18
CN1658839A (zh) 2005-08-24
EP1494644A1 (en) 2005-01-12
AU2003217073A1 (en) 2003-11-03
MXPA04010080A (es) 2004-12-13

Similar Documents

Publication Publication Date Title
DK1689360T3 (da) Tørpulverformuleringer
NO20035251D0 (no) Törrpulverinhalator
DK3536344T3 (da) Superfin formoterolformulering
PT1501534E (pt) Formulacoes farmaceuticas
FR2842417B1 (fr) Composition cosmetique
FR2842416B1 (fr) Composition cosmetique
IS8309A (is) Lyfjablöndur
ATE460955T1 (de) Trockenpulver-inhalator
DE60118496D1 (de) Pulverzusammensetzung
DE60311307D1 (de) Shampoo-zusammensetzungen
NO20043418L (no) Stabiliserte adenovirusformuleringer
DE60310914D1 (de) Pulverzusammensetzung
IS7501A (is) thurrdufts innöndunar samsetning
DK1561472T3 (da) Faststofsammensætning
DK1596870T3 (da) Höjdosis-iblandronatformulering
DK1539089T3 (da) Reducerede aerosol-genererende formuleringer
IS7500A (is) thurrdufts samsetningar
DE60221611D1 (de) Trockenpulverinhalator
IS7582A (is) Hraðlosandi lyfjablanda
ITMI20011532A0 (it) Cosmetico solido
DE60326900D1 (de) Duftstoff-Zusammensetzung
ATE382264T1 (de) Trockenhefe-komposition
DE60123539D1 (de) Puderquaste
GB0218194D0 (en) Solid formulations
DK1567135T3 (da) Tiotropiumholdig pulverformulering til inhalation